ABSTRACT ToxR is a major virulence gene regulator in Vibrio cholerae. Although constitutively expressed under many laboratory conditions, our previous work demonstrated that the level of ToxR increases significantly when cells are grown in the presence of the 4 amino acids asparagine, arginine, glutamate, and serine (NRES). We show here that the increase in ToxR production in response to NRES requires the Var/Csr global regulatory circuit. The VarS/VarA two-component system controls the amount of active CsrA, a small RNA-binding protein involved in the regulation of a wide range of cellular processes. Our data show that a varA mutant, which is expected to overproduce active CsrA, had elevated levels of ToxR in the absence of the NRES stimulus. Conversely, specific amino acid substitutions in CsrA were associated with defects in ToxR production in response to NRES. These data indicate that CsrA is a positive regulator of ToxR levels. Unlike previously described effects of CsrA on virulence gene regulation, the effects of CsrA on ToxR were not mediated through quorum sensing and HapR. CsrA is likely essential in V. cholerae, since a complete deletion of csrA was not possible; however, point mutations in CsrA were tolerated well. The CsrA Arg6His mutant had wild-type growth in vitro but was severely attenuated in the infant mouse model of V. cholerae infection, showing that CsrA is critical for pathogenesis. This study has broad implications for our understanding of how V. cholerae integrates its response to environmental cues with the regulation of important virulence genes. 
of these genes, but with opposite effects: whereas ompU expression is upregulated by ToxR, ompT expression is repressed (10) (11) (12) . OmpT has greater overall permeability than OmpU (13) and is thought to be the dominant porin during growth in the aquatic environment, where the concentration of nutrients and osmolytes may be relatively low. OmpU, although it has a slightly larger pore size than OmpT, is less permeable to negatively charged compounds (13) . Consequently, OmpU is essential for resistance to bile acids and organic acids, as well as to many antimicrobial peptides, present in the digestive tract of the host (14, 15) . OmpU is expressed at high levels, both during infection of the human host and during shedding in the stool of cholera patients (16, 17) .
The mechanism of ToxR-dependent transcriptional regulation in response to environmental cues is not completely understood. Previous studies have shown that toxR expression is not generally responsive to environmental conditions that favor virulence gene expression in vitro, suggesting that toxR expression may be constitutive under most laboratory conditions (8, (18) (19) (20) . We have demonstrated, however, that ToxR levels are modulated in vitro in response to specific environmental cues. ToxR protein levels increase rapidly in minimal medium upon addition of a mix of asparagine, arginine, glutamate and serine (NRES), and this increase in the level of ToxR is sufficient to promote production of OmpU while reducing synthesis of OmpT (8) . In this study, we demonstrate that modulation of ToxR levels in response to the NRES mix is dependent upon the two-component system VarS/ VarA and the global regulator CsrA.
Homologs of the VarS/VarA system are found in many bacterial species, including Escherichia coli (BarA/UvrY) and Pseudomonas species (GacS/GacA). These systems regulate processes as diverse as central carbon metabolism, motility, biofilm formation, quorum sensing, production of virulence determinants, and oxidative stress (reviewed in references 21 and 22) . In V. cholerae, the VarS/VarA system is involved in carbon metabolism (23) , quorum sensing and biofilm formation (24, 25) , expression of virulence determinants (26, 27) , fitness in infant mice and rabbits (23, 27) , and survival in pond water after being shed from the mammalian host (23) . VarS is predicted to be a sensor kinase that phosphorylates and activates its cognate response regulator VarA in response to an unknown signal. Activated VarA induces transcription of three noncoding small RNAs (sRNAs), CsrB/C/D (25) , which bind the regulatory protein CsrA and sequester it in an inactive state (Fig. 1) . Each of the three V. cholerae Csr sRNAs contains multiple CsrA recognition sequences and is predicted to bind 15 to 20 CsrA molecules (25) , as has been shown for the CsrA-antagonizing sRNA CsrB in E. coli (28) . CsrA is a global, posttranscriptional regulator that acts by binding to mRNA targets and affecting their translation or stability. CsrA is likely the primary target of signaling through the VarS/A system in V. cholerae (25) , but it is not known whether the CsrA/B/C/D system is subject to VarS/A-independent regulation.
We show here that a varA mutant of V. cholerae, which is predicted to overproduce active CsrA due to poor expression of the CsrB/C/D sRNAs, had elevated levels of ToxR and OmpU in the absence of the NRES signal. This suggests that CsrA has a stimulatory effect on ToxR levels. Consistent with this, we identified a series of CsrA point mutants that failed to increase ToxR levels or produce OmpU in response to the NRES mix. One of these point mutants, CsrA Arg6His, was tested in vivo and failed to colonize infant mice, showing that CsrA is critical for the virulence of V. cholerae. The interconnection of the CsrA global regulatory circuit with the ToxR regulon has important implications for how V. cholerae incorporates environmental cues into the complex regulation of its virulence genes.
RESULTS

The transcriptional profile of V. cholerae in response to NRES.
Our previous studies demonstrated that growth of V. cholerae in a minimal medium containing the NRES amino acid mix caused ToxR levels to increase, resulting in a switch in the dominant porin from OmpT to OmpU (8) . To better understand the nature of the response to amino acid stimulation in V. cholerae, changes in V. cholerae gene expression in response to the NRES mix were determined by microarray analysis. A list of V. cholerae genes for which the transcript level was altered more than 2-fold in response to NRES can be found in Table S1 in the supplemental material. These include genes involved in amino acid and carbon metabolism, peptide transporter genes, genes related to quorum sensing, biofilm formation, and chemotaxis, virulence genes, including toxR, toxS, and varA, iron transport genes, a putative 54 modulation factor gene, the porin genes ompT and ompU, genes encoding hypothetical proteins, and many others. Several of the NRESresponsive genes were tested by mutant analysis to determine whether they played a role in the NRES-dependent ToxR increase and OMP switching (see Table S2 in the supplemental material). As expected, toxR and toxS mutants did not produce OmpU under any condition (8) ; however, only one additional NRES-regulated gene tested in this study, varA, displayed a mutant phenotype with respect to its OMP profile. Other genes known to play a role in the virulence of V. cholerae were tested as well, but none were found to be required for OMP switching in response to NRES (Table S2) , making it unlikely that they participate in NRES-mediated regulation of ToxR levels.
VarA plays a role in the NRES response. The VarS/A system is involved in quorum sensing and virulence gene regulation in V. cholerae (25) (26) (27) . Interestingly, the gene encoding the response regulator VarA showed a 2-to 3-fold induction in the presence of NRES. Therefore, a varA mutant was constructed in V. cholerae El Tor strain N16961 and tested for its ability to respond to the NRES mix.
The N16961 varA mutant (NvarA) produced a mixture of large and small colonies. The small-colony variant, NvarA S , exhibited reduced growth in liquid culture compared with the wild-type indicate that the exact mechanism of regulation is currently unknown. We show here that CsrA positively regulates the level of ToxR protein in response to amino acids. Var/Csr-mediated regulation of biofilm and virulence gene expression via the quorum sensing pathway is described by Lenz et al. (25) . The regulation of omp gene expression by ToxR is well established (8, 10 -12, 14) .
parental strain, especially in a minimal medium ( Fig. 2A) . Growth was restored to wild-type levels when pVarA, a low-copy-number plasmid containing the cloned varA gene, was introduced into the NvarA S strain ( Fig. 2A) , showing that the poor growth of NvarA S was due solely to the lack of a functional VarA.
When grown in a minimal medium, the NvarA S strain had an abnormal OMP profile, producing both OmpT and OmpU, whether or not NRES was present (Fig. 2B) . Alterations in the OMP profile often indicate misregulation of ToxR levels. Indeed, in the absence of amino acids, the level of ToxR was much higher in the NvarA S strain than in the parental strain (Fig. 2B ). This increase in ToxR could reasonably account for the presence of OmpU in the NvarA S strain grown without any added NRES, as an increase in ToxR protein levels above basal levels is sufficient to induce ompU expression (8) .
In contrast to NvarA S , the large-colony NvarA strain (NvarA L ) had a normal growth phenotype compared with its wild-type parental strain (see Fig. S1 in the supplemental material) but did not produce any OmpU in response to NRES when grown in a minimal medium (Fig. 3A) . This was not due to an inherent inability to synthesize OmpU, since NvarA L made OmpU exclusively when grown in medium containing the bile salt cholate (Fig. 3B) , a condition known to promote the production of OmpU and repress the synthesis of OmpT (8) . These data suggest that NvarA L specifically cannot respond to NRES. The switch from ompT to ompU expression in response to NRES requires an increase in the level of ToxR, unlike the response to bile acids, in which the ToxR level is unchanged (8) . To determine whether the inability to produce OmpU in the NvarA L strain is due to failure to upregulate the production of ToxR in response to the NRES mix, ToxR levels were assessed. The results show that ToxR levels did not increase in NvarA L grown with NRES (Fig. 3A) , suggesting that the level of ToxR is insufficient to promote a switch in omp gene expression from ompT to ompU under these conditions. When pVarA was introduced into NvarA L for complementation, it did not restore NRES-mediated OmpU production, nor did it cause an increase in ToxR levels in response to NRES (Fig. 3A) . This suggested that the NvarA L strain contains a suppressor mutation that allows for relatively robust growth compared with the NvarA S strain but which disrupts the induction of ToxR and OmpU levels in response to NRES.
Loss of VarA results in suppressor mutations in csrA. Since loss of VarA is predicted to result in overaccumulation of active CsrA due to low levels of the CsrA-sequestering sRNAs (Fig. 1) , we reasoned that suppressor mutations could arise in the csrA gene itself. The csrA gene from the NvarA L strain was sequenced and was found to contain a point mutation that replaces the arginine residue at amino acid position 6 with a histidine (R6H). Several independently derived NvarA L isolates were analyzed to determine whether they also carried suppressor mutations in csrA and whether there was variation in the type of csrA point mutation that could arise in the absence of functional VarA. All of the NvarA L isolates tested carried point mutations affecting csrA. In contrast, none of the small colony phenotype NvarA S strains had mutations in csrA. Most of the NvarA L strain mutations were in the csrA coding region, but several isolates carried mutations in the predicted Shine-Dalgarno (SD) sequence upstream of the csrA trans- and NvarA S were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in midlog phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue (top panel) or immunoblotted using polyclonal anti-ToxR antisera (bottom panel). lational start (Fig. 4) . All coding region mutations resulted in a single amino acid substitution in CsrA (Fig. 4) . The OMP profiles of several NvarA L suppressor mutants were analyzed. Many of these mutants did not produce OmpU in response to the NRES mix (Fig. 5A ). Rather, they produced OmpT at high levels in minimal medium both with and without NRES supplementation. Thus, these mutants were not stimulated to switch OMPs in the presence of NRES. The amino acid substitutions in this group of mutants generally clustered in the N-terminal half of CsrA (R6H, R6L, T11P, I14T, and T19P) (Fig. 4) . Another class of point mutants produced both OmpT and OmpU in T medium alone, and this pattern did not change with the addition of NRES, suggesting defects in OMP regulation in response to environmental cues (Fig. 5A ). Several mutants of this class had amino acid substitutions localizing to a region within the C-terminal half of the CsrA protein (A36S and P37L) (Fig. 4) . Some of the suppressor strains had mutations in the putative SD sequence (Fig. 4 ). These mutants were phenotypically similar to the class of mutants exhibiting no OmpU production in response to NRES ( Fig. 5A ; also data not shown).
The level of ToxR was determined in each of these suppressor mutants. In the mutants producing no detectable OmpU in response to NRES, the level of ToxR was found to be correspondingly low, indicating that the point mutations in CsrA abolished the NRES-mediated increase in ToxR protein levels (Fig. 5B ). In the strains that produced a small, constitutive amount of OmpU 
and NvarA L -7 (P37L) were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue (A) or immunoblotted using polyclonal anti-ToxR antisera (B).
with or without NRES, the level of ToxR protein was higher than normal in the absence of NRES but lower than normal in the presence of NRES (Fig. 5B) ; thus, the amount of ToxR produced was large enough to promote some OmpU synthesis in the absence of NRES but not sufficient to cause a complete switch in OMP production from OmpT to OmpU (Fig. 5A ). The inappropriate production of ToxR and OmpU in the absence of NRES seen in this group of NvarA L suppressor strains might result from constitutively high levels of free (albeit less active) mutant CsrA, since the varA mutant strains do not produce the CsrAsequestering sRNAs ( Fig. 1 ). High levels of active CsrA cause growth defects and overproduction of ToxR and OmpU in the absence of NRES. Complementation experiments were carried out in order to rescue the csrA defect of the NvarA L mutant strains by supplying the csrA gene on a low-copy-number vector; however, the mutant strains did not tolerate the csrA plasmid well, and most of the strains failed to maintain the plasmid. This is not surprising, since the varA mutation impairs the ability of the strain to control the level of free CsrA, which is likely detrimental for growth, as shown above. Only one of the NvarA L strains, NvarA L -3 (⌬varA::cam csrA.T11P), maintained the pWCsrA plasmid well enough for analysis. This strain exhibited very poor growth when carrying the pWCsrA plasmid but normal growth when carrying the vector alone (Fig. 6A) . The presence of the pWCsrA plasmid did not restore the OMP profile to normal. Rather, OmpU was inappropriately expressed when the mutant strain carrying this plasmid was grown in T medium alone (Fig. 6B) , suggesting overproduction of ToxR, even in the absence of an environmental cue. This is likely due to constitutively high levels of free CsrA in the absence of a functional VarA system and suggests that CsrA acts as a positive regulator of ToxR synthesis. The pWCsrA plasmid had no effect on the OMP profile of the wild-type strain grown with or without the NRES supplement (see Fig. S2 in the supplemental material). This is consistent with tight regulation of CsrA levels by the VarS/A-CsrB/C/D system in the wild-type strain to prevent toxic levels of free CsrA.
An Arg6His substitution in CsrA is sufficient to abolish NRES-mediated ToxR production. To test directly the role of CsrA in the regulation of ToxR protein levels, attempts were made to delete the entire csrA gene in strain N16961; however, none of these attempts was successful, suggesting that csrA is essential in V. cholerae. Instead, we tested whether a point mutation in CsrA alone is sufficient to abolish the ToxR/OMP response to the NRES mix. The csrA R6H point mutation, which was one of the most frequently isolated mutations, was constructed in the wild-type genetic background. The NcsrA.R6H strain exhibited wild-type growth (data not shown) but produced only OmpT, and no OmpU, in the presence of the NRES mix (Fig. 7A) , indicating that the csrA point mutation, and not the varA deletion, caused the failure to respond to the NRES mix in the original NvarA L -1 strain. As in the NvarA L -1 strain, the ToxR levels in the NcsrA.R6H point mutant did not increase in the presence of NRES (Fig. 7B) . This shows that changing just a single amino acid in CsrA profoundly affects the ability of V. cholerae to respond to amino acids. To verify that the NcsrA.R6H point mutant did not contain any additional suppressor mutations that might be responsible for the observed phenotype, the point mutant was complemented. A csrA plasmid clone was created in a single-copy-number vector, pCC1. When pFCsrA was introduced into NcsrA.R6H, both the OMP profile and the ToxR level were restored to wild type ( Fig. 7A and B). This shows that the R6H point mutation in CsrA is solely responsible for the defect in ToxR/OmpU production. Expression of csrA from the pFCsrA plasmid did not interfere with regulation NRES, even when the Var system is functional. The wild-type strain N16961, the NcsrA.R6H mutant, the vector control strain NcsrA.R6H/pCC1, and the complemented strain NcsrA.R6H/pFCsrA were grown overnight in LB broth and then subcultured 1:100 into T medium with or without 12.5 mM NRES mix. Cells were harvested in mid-log phase, and whole-cell preparations were resolved by SDS-PAGE (10%) and stained by Coomassie blue (A) or immunoblotted using polyclonal anti-ToxR antisera (B).
of the OMPs in the wild-type strain (see Fig. S2 in the supplemental material), most likely due to tight regulation of free CsrA levels by the VarS/A-CsrB/C/D system. A csrA::Tn5 carboxy-terminal insertion mutant is defective in NRES-mediated ToxR production. Although we were unable to create a csrA deletion mutant in V. cholerae, a csrA::Tn5 mutant has been isolated and shown to affect quorum sensing pathways in V. cholerae strain C6706str2 (25) . Interestingly, when the csrA:: Tn5 allele was sequenced, we found that the site of the Tn5 insertion was at the end of the csrA gene, in a position nearly identical to the transposon insertion in a published, viable E. coli csrA::kan mutant (29, 30) (Fig. 4) . This suggests that the V. cholerae csrA:: Tn5 mutant, like the E. coli csrA::kan mutant, may produce a partially functional CsrA. This is further supported by the absence of any growth defect in the V. cholerae csrA::Tn5 mutant (25; also data not shown). An identical csrA::Tn5 insertion mutation was created in strain N16961. As shown in Fig. 4 , this insertion results in the loss of the C-terminal 12 amino acid residues of V. cholerae CsrA. NcsrA::Tn5 exhibited wild-type growth in rich medium (data not shown), suggesting that the C-terminally truncated CsrA protein retains the activities needed for viability; however, similar to the NcsrA.R6H strain, NcsrA::Tn5 produced very low levels of ToxR and OmpU in response to NRES (see Fig. S3A and B in the supplemental material). Wild-type OMP and ToxR levels were fully restored when csrA was supplied on plasmid pFCsrA (see Fig. S3A and B) .
The outgrowth of csrA suppressor mutants is not due to overproduction of a ToxR-regulated target. As described in Fig. 1 , mutation of varA leads to an increase in the level of free CsrA and therefore in the level of ToxR. Thus, the selective pressure to mutate csrA in a varA mutant strain background could be a result of overproduction of a ToxR-activated target, such as OmpU, in the varA mutant. To investigate this, a varA deletion was created in a toxR-defective strain. Both large and small colonies were observed for the resulting toxR varA mutants, suggesting the outgrowth of suppressor mutants (large colonies). The csrA gene was sequenced in a number of these double mutants. All large colonies had csrA point mutations (Fig. 4) , whereas the small colonies were wild type for csrA. This demonstrates that suppressor mutations leading to improved growth of the varA mutant are selected for even in the absence of toxR, showing that misregulation of a ToxRactivated gene is unlikely to be the selective pressure responsible for the outgrowth of csrA suppressors in the varA mutant. Thus, the pressure to mutate csrA in the absence of varA may be due to misregulation of another, unknown, CsrA target.
HapR and LuxO are not needed for the NRES response. V. cholerae CsrA has been shown to regulate the expression of genes involved in quorum sensing, biofilm formation, and virulence, primarily through the regulatory protein HapR, which integrates signals from multiple pathways, including the Lux quorum sensing pathway and the VarS/A-CsrA system (25, 31) . The strain used in these studies, N16961, is naturally defective for hapR (32) , suggesting that HapR is not needed for NRES-mediated regulation. Although N16961 does not produce functional HapR, it may produce another factor with a redundant function. To determine directly whether either quorum sensing or HapR plays a role in the CsrA-mediated regulation of ToxR levels in response to NRES, we tested the effects of various mutations in a HapR ϩ strain, C6706, which responds similarly to NRES as N16961 (see Fig. S4 in the supplemental material) . Similar to the NvarA S strain, a C6706 varA mutant grew poorly and produced ToxR and OmpU in the absence of NRES, all of which could be remedied by supplying wild-type varA on a plasmid (data not shown). These data suggest that C6706 does not differ significantly from the HapRdefective N16961 strain in its response to NRES and the role of VarA in this; however, it did not rule out that HapR is needed for some aspect of this response in C6706. Therefore, a C6706 hapR mutant was tested for its role in the NRES regulation. No differences were detected between the wild-type parental strain and the hapR mutant with respect to OMP and ToxR levels in the presence of NRES (see Table S2 in the supplemental material), indicating that HapR is not required for the NRES response. The quorum sensing regulator, LuxO, which has been shown to play a role in relaying input from the Var/Csr pathway into the quorum sensing pathway (25), was not necessary for the NRES response either (see Table S2 ). This suggests that the mechanism of CsrA regulation of ToxR levels does not require either the Lux quorum sensing pathway or the HapR transcriptional regulator.
CsrA is required for virulence. ToxR is a critical virulence factor within the mammalian host (4, 33, 34) , suggesting that functional CsrA may also be necessary for the pathogenesis of V. cholerae. To test this, we assessed the ability of the NcsrA.R6H mutant to colonize infant mice. The infant mouse model has been shown to be effective in demonstrating the importance of many major virulence factors in this pathogen (35) . A competition assay was performed to compare the in vivo fitness of the NcsrA.R6H point mutant to that of the wild-type strain. As described earlier, the NcsrA.R6H strain was not impaired in its in vitro growth but failed to increase ToxR and OmpU levels in response to the NRES mix. Five-day-old infant mice were inoculated intragastrically with equal numbers of the wild-type strain and the NcsrA.R6H mutant. The ability of the mutant strain to compete with the wildtype strain was assessed by determining the ratio of viable mutant cells to wild-type cells recovered after 18 h. The median competitive index (CI [i.e., the output ratio normalized to the input ratio]) for the NcsrA.R6H mutant was Ͻ0.01, showing a severe defect in the ability to colonize the infant mouse (Fig. 8) . Four of the nine animals yielded results that were below the limit of detection (CI, Ͻ0.005), and therefore the median CI is likely even lower than what was computed. These data point to an overall decrease in fitness of more than 100-fold for the mutant strain, showing that CsrA is critical for colonization of the small intestine.
DISCUSSION
V. cholerae is a facultative human pathogen that spends most of its life cycle in aquatic habitats. The transition to the human host represents a major environmental shift that includes changes in temperature, pH, osmolarity, and the level of both nutrients and antimicrobial compounds. V. cholerae must sense and respond to these environmental cues in order to survive the initial transit through the upper portions of the digestive tract and become oriented toward the most favorable microenvironment for successful colonization and production of the cholera toxin within the lower part of the small intestine.
In V. cholerae, as well as in other human pathogens, the global regulator CsrA plays an important role in coordinating the cellular response to multiple environmental signals, including nutritional status and cell density (23, 25, 36) . In this study, we demonstrate a link between CsrA and regulation of ToxR levels in response to an environmental signal. CsrA was essential for the increase in ToxR that occurred when V. cholerae grew in the presence of the NRES amino acids and for the subsequent alterations in the outer membrane protein profile. We show further that CsrA is critical for the virulence of V. cholerae; this is the first definitive study of the role of V. cholerae CsrA in vivo.
CsrA was shown previously to affect pathways leading to virulence gene expression in V. cholerae, but not via ToxR. Most of the effects of the CsrA signaling cascade on virulence gene expression in V. cholerae have been found to be relayed through HapR, either via quorum sensing and the Lux pathway (25) or through Luxindependent effects on HapR activity (37) . HapR-independent regulation of a virulence gene by CsrA has not been demonstrated. However, in at least one HapR Ϫ strain of V. cholerae, O395 (38), VarA is required for production of virulence factors and for pathogenesis in mice (27) . This suggests that there is HapRindependent regulation of the V. cholerae virulence regulon through the Var/Csr system. Here, we show that the interconnection between the CsrA pathway and the ToxR regulon occurs independently of both HapR and the central quorum sensing regulator LuxO.
Our data suggest a model in which CsrA acts as a positive regulator of ToxR synthesis. A V. cholerae VarA system mutant, which is predicted to produce too much active CsrA (25) , exhibited abnormally high levels of ToxR and OmpU in minimal medium without amino acid supplementation. Overexpression of csrA from a plasmid in the absence of functional VarA caused a similar increase in ToxR and OmpU levels in the absence of the NRES signal. In addition, mutation of csrA, either through a point mutation or a transposon insertion, was associated with failure to upregulate ToxR levels in the presence of NRES, further establishing the requirement for CsrA in the ToxR-mediated response to amino acids.
CsrA can act as a positive or a negative regulator, depending on whether it increases or decreases either translation or stability of the target mRNA (reviewed in reference 22). Studies are under way to determine whether the observed positive effects of CsrA on ToxR regulation are direct or indirect. Putative binding sites for CsrA can be found in the region upstream of the predicted start of translation of the toxR mRNA (A. R. Mey, unpublished results), suggesting that CsrA may bind directly to the toxR transcript and increase its stability or rate of translation. The exact mechanism for this proposed regulation is not clear, since the putative CsrA binding sites are in close proximity to the proposed ShineDalgarno sequence in the predicted toxR transcript, which is more typical of translational repression. It should be noted, however, that experimental verification of the predicted start sites for toxR transcription and translation in V. cholerae has not been published. At least one study has suggested an alternative start of translation for ToxR (39) , and this could have implications for the mechanism by which CsrA influences ToxR levels. In addition, new mechanisms of regulation by CsrA are still being uncovered, and there is much still to learn about how this important global regulator operates at its various mRNA targets.
Our studies suggest that csrA is essential in V. cholerae, as we were unable to construct a complete deletion of the csrA gene. In E. coli, CsrA is essential under laboratory conditions (30) , and most published studies of csrA function in E. coli have been carried out using a strain carrying a transposon insertion at codon 51 out of 65 (Fig. 4) , resulting in a partially active CsrA protein (29, 30) . The published, viable V. cholerae csrA::Tn5 mutant carries an insertion in a similar position, suggesting that it may also retain partial CsrA activity. It has been proposed that the lethality of a csrA null mutant could be due in part to accumulation of excess glycogen (30) , since CsrA is known to repress the glycogen biosynthetic pathway (29) ; however, we were unable generate a complete csrA deletion mutant in a glycogen synthesis-deficient strain of N16961 (40) , suggesting that csrA is essential for the growth of V. cholerae for reasons other than or in addition to regulation of glycogen biosynthesis (H. A. Butz, unpublished results).
While loss of csrA is harmful to the cell, too much CsrA is detrimental as well. The level of active CsrA is tightly controlled through the CsrB/C/D sRNAs and by the VarS/VarA twocomponent system that regulates their expression. Our studies suggest that a constitutively high level of active CsrA through loss of VarA in V. cholerae causes growth defects, resulting in the accumulation of suppressor mutations in csrA. The varA csrA* suppressor strains exhibited normal growth compared with the varA mutant alone, but poor growth returned when wild-type csrA was supplied on a plasmid, further evidence that overproduction of active CsrA is damaging to the cell. A suppressor mutation in the csrA gene was identified also by Kamp et al. (23) during their studies of a V. cholerae El Tor strain E7946 varS mutant. The mutation was mapped to the start codon of csrA and was predicted to decrease the amount of CsrA made. Kamp et al. noted that the varS csrA* suppressor strain survived nutrient-limiting conditions far better than the varS mutant alone, suggesting that high levels of active CsrA impaired growth in this strain as well. A high rate of suppressor mutations in response to misregulation of CsrA levels has not been reported in other bacterial species. In E. coli, mutants with mutations in the BarA/UvrY two-component system do not grow poorly except when glycolytic carbon sources are used (41) , and no csrA suppressor mutations have been reported for these mutant strains. Not surprisingly, active CsrA levels are tightly con- Arg6His point mutant NcsrA.R6H was competed against the wild-type strain N16961G. Five-day-old suckling BALB/c mice were inoculated intragastrically with an equal number of each competing strain as described in Materials and Methods. The competitive index (CI) was calculated by normalizing the output ratio to the input ratio of the two competing strains. Each data point represents one mouse, and the median CI (0.01) is represented by the solid horizontal line. A CI value below 1 indicates that the mutant is at a competitive disadvantage. The dotted line shows the limit of detection for the CI in this experiment, which was 0.005. In 4 out of 9 mice, the mutant was not detected during analysis of more than 200 recovered colonies, and thus the CI falls below the limit of detection. These data points are included in the analysis as having a value of 0.005, which is the most conservative estimate for the CI. The actual CI values are likely to be lower. The results were statistically significant (P Ͻ 0.05) by the Mann-Whitney nonparametric test.
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An important question that remains is how the NRES amino acids control the level of active CsrA. The specific sensing mechanism for the NRES mix is not known, and it is unclear whether the VarS/A system is responsible for relaying the NRES signal. The transcriptional profile of V. cholerae in response to NRES showed no changes in the level of the varS and csrA transcripts, while the level of the varA transcript was increased. An increase in VarA should lower the level of active CsrA, but instead, active CsrA levels were higher in the presence of NRES. The increase in varA transcript levels could be due to feedback regulation from CsrA, since CsrA has been shown to positively affect transcription of the varA homolog uvrY in E. coli (43) . In E. coli, CsrB sRNA levels were greatly reduced when cells were grown in the presence of amino acids (44) , which could lead to an increase in active CsrA levels. We are currently investigating whether this may also be the case in V. cholerae.
V. cholerae CsrA is a small, 65-amino-acid protein with 84% amino acid identity to E. coli CsrA (Fig. 4) . The three-dimensional structure of CsrA (or its homologs RsmA/RsmE) has been solved in E. coli (45) , Pseudomonas putida (46) , Pseudomonas fluorescens (47) , and Yersinia enterocolitica (48). Based on the high level of amino acid conservation between these proteins and V. cholerae CsrA, it is likely that V. cholerae CsrA is very similar in structure. In these structures, CsrA is a homodimeric barrel-shaped protein made up of intertwined ␤ sheets from each of the CsrA subunits, with two wing-like ␣-helical extensions. Alanine-scanning mutagenesis identified two regions of CsrA that are in close proximity to each other and that are critical for both RNA binding and regulatory activity (49) . These regions encompass the first (amino acid residues 2 to 7) and the fifth (amino acid residues 40 to 47) ␤ strands of CsrA (Fig. 4) . ␤ strand 1 is the most highly conserved region among CsrA proteins from a diverse range of bacterial species, and several residues in ␤ strand 5 are invariable as well (49) (Fig. 4) . ␤ strand 1 from one CsrA subunit interdigitates with ␤ strand 5 from the other subunit to form one of the two positively charged, solvent-accessible faces of the dimer. These are the regions of the CsrA dimer believed to be primarily involved in binding RNA. A large proportion of the point mutants isolated in this study clustered within the first ␤ strand or in the region immediately following, confirming the importance of the N-terminal domain for CsrA function (Fig. 4) . Arg6 was one of the most commonly mutated residues in V. cholerae CsrA in response to misregulation of CsrA levels in the varA mutant. It was shown in Pseudomonas fluorescens that an R6A substitution in the CsrA homolog RsmE, which has been cocrystallized with its target mRNA, hcnA (47) , was associated with a complete failure to repress translation of the hcnA transcript (50), pointing to the critical nature of this residue. It was also demonstrated by structural analyses of Y. enterocolitica RsmE that Arg6 forms an important salt bridge with Glu46 which helps to stabilize the ␣-helical extension from each face of the dimer (48) . Not surprisingly, a truncation of the C terminus was associated with defects in CsrA function, likely due to effects on the ␣ helix and the adjacent RNA-binding domain. It is important to reiterate that the point mutants, as well as the csrA::Tn5 insertion mutant, obtained in this study retained some vital functions of CsrA, since the strains did not exhibit the growth defects associated with either overproduction or the complete absence of active CsrA.
Because csrA is essential, it has been difficult to study the role of CsrA in virulence. We show here that mutation of a single amino acid residue of CsrA is sufficient to abolish its ability to mediate an increase in the level of a major virulence gene regulator, ToxR, in response to amino acids. The NcsrA.R6H point mutant exhibited no growth defects in vitro compared with its wild-type parental strain; however, the mutation had a profound effect on the ability of V. cholerae to colonize infant mice. ToxR is one of the most important regulators of virulence gene expression in this pathogen. ToxR controls expression of the major V. cholerae virulence factors (4, 5) and is essential for causing disease in both humans and mice (33, 34) . This might suggest that the ability to regulate ToxR levels in response to certain nutrients could be important in vivo; however, it is important to recognize that CsrA is a global regulator with pleiotropic effects on carbon metabolism, quorum sensing, biofilm production, and other processes that could influence the ability of V. cholerae to cause disease in the mammalian host. Our studies cannot distinguish between the CsrA-mediated increase in ToxR levels and another function of CsrA needed for colonization and virulence; nevertheless, these studies have demonstrated a clear requirement for CsrA in V. cholerae pathogenesis separate from its essential viability functions, and we have uncovered a previously unknown relationship between CsrA and ToxR. The regulation of ToxR levels by CsrA in response to amino acids adds another dimension to the complex network of transcriptional, translational, and posttranslational mechanisms for ensuring maximal ToxR activity at the appropriate times within the diverse environments occupied by this important pathogen.
MATERIALS AND METHODS
Bacterial strains and plasmids, and growth conditions. Bacterial strains and plasmids used in this study are listed in Table S3 in the supplemental material. All strains were maintained at Ϫ80°C in tryptic soy broth (TSB) plus 20% glycerol. Strains were routinely grown at 37°C in Luria-Bertani (LB) broth (1% tryptone, 0.5% yeast extract, 1% NaCl [wt/vol]) (51) or in T medium (52) modified to contain 0.2% wt/vol sucrose, 20 M FeSO 4 , and a mixture of vitamins (recipe for 100ϫ VA vitamin solution at http:// www.genome.wisc.edu/resources/protocols/ezmedium.htm). Amino acids (Sigma) for the NRES supplement were dissolved in water and used at a final concentration of 12.5 mM total amino acids (3.125 mM each amino acid), unless otherwise indicated. Cholate was used at 0.1% (wt/vol). Antibiotics were used at the following concentrations for E. coli strains: 50 g/ml ampicillin, 50 g/ml kanamycin, and 30 g/ml chloramphenicol. For V. cholerae strains, the concentrations used were 25 g/ml ampicillin, 25 g/ml kanamycin, 6 g/ml chloramphenicol, 30 g/ml gentamicin, and 20 g/ml polymyxin B. Plasmid clones were transferred to V. cholerae strains by electroporation or bacterial conjugation, as described previously (53) .
PCR. The oligonucleotide primers for PCR were purchased from Sigma-Aldrich (St. Louis, MO) and Invitrogen (Carlsbad, CA). Primers used for cloning are listed in Table S4 in the supplemental material. PCR was performed using KOD Hot Start DNA polymerase (Novagen, EMD Chemicals, San Diego, CA) to create fragments for cloning and Taq DNA polymerase (Qiagen, Valencia, CA) for all general verification purposes. PCRs were carried out according to the manufacturer's instructions, using the primers described below. Unless otherwise indicated, the template for PCR was bacterial whole-cell suspensions in water. All clones derived from PCR products were verified by DNA sequencing.
Sequence analysis. DNA sequencing was performed by the University of Texas, Institute for Cellular and Molecular Biology DNA Core Facility using the capillary-based 3730 DNA analyzer from Applied Biosystems (Foster City, CA). Analysis of DNA sequences was carried out using MacVector 12.0.6. BLAST searches and other bioinformatic analyses were done using the National Center for Biotechnology Information (NCBI) and the Comprehensive Microbial Resource (CMR) databases. Pairwise alignments were carried out using ClustalW from within MacVector 12.0.6.
Construction of plasmids, strains, and chromosomal mutations. To create pVarA, the varA gene (VC1213) was amplified from V. cholerae strain C6706 by PCR using primers varA.F and varA.R. The resulting PCR product was cloned into pWKS30 digested with SmaI to yield pVarA. The V. cholerae csrA gene (VC0548) was cloned by PCR amplification of the csrA gene from strain N16961 using primers csrA3 and csrA4. The resulting fragment was cloned into the PmlI site of the single copy vector pCC1 to create pFcsrA, or into the SmaI site of pWKS30 to create pWCsrA.
To create strain N16961G (the wild-type strain, N16961, carrying a gentamicin cassette in the Tn7att site), we used the protocol described by McKenzie and Craig (54) . pGRGgent1 (E. E. Wyckoff) was transferred to N16961 by bacterial conjugation, and transconjugants were selected at 30°C on polymyxin B and ampicillin for maintenance of the temperature-sensitive plasmid. Strains were grown at 42°C in order to facilitate loss of the plasmid and then screened on gentamicin and ampicillin to identify candidates that had lost the plasmid, but retained the gentamicin cassette. Gen r Amp s candidate N16961G strains were screened by PCR with primers IntF1 and IntR1 to verify insertion of the gentamicin cassette in the Tn7att site.
To create a chromosomal deletion of the varA gene, two fragments with a short overlap were generated by PCR using primer sets varA.F/ VarA.Sma.1 and VarA.Sma.2/varA.R. The overlapping fragments were then used as the template to generate a splice overlap extension (SOE) PCR product using primers varA.F and varA.R. The final PCR fragment, ⌬varA::SmaI, was cloned into the SmaI site of pWKS30, and the resulting plasmid was digested with SmaI to insert a chloramphenicol resistance cassette, yielding pWKS30 carrying ⌬varA::cam. The ⌬varA::cam fragment was subcloned as an XbaI/EcoRV fragment into pHM5 digested with XbaI/EcoRV to yield the allelic exchange construct pAMS30. To create the V. cholerae csrA.R6H point mutation, the csrA.R6H allele was amplified from strain NvarA L -1 using KOD Hot Start polymerase and primers csrA3.Sal and csrA4.Bam. The PCR product was digested with SalI and BamHI and ligated into pHM5 digested with SalI and BglII to create allelic exchange construct pAMS31. To create the Tn5 insertion in csrA, fragments with a short overlap were generated using primers csrA3 and csrA2 to amplify one segment from V. cholerae strain dl2395 (which carries the csrA::Tn5 allele [generously provided by B. Bassler]), and primers csrA7 and csrA4 to amplify the other segment from the wild-type strain N16961. The overlapping segments were used as the template for SOE PCR with primers csrA3 and csrA4 to generate the complete csrA::Tn5 fragment with flanking sequences. The csrA::Tn5 fragment was cloned as a blunt fragment into pCVD442N digested with SmaI to create allelic exchange construct pAMS32. Allelic exchange constructs were transferred to V. cholerae strains via bacterial conjugation, and allelic exchange was carried out as described previously (55, 56) .
SDS-PAGE and immunoblotting. Cultures were grown overnight in LB medium and diluted 1:100 into fresh medium, as described above and in the figure legends. Cultures were grown to the mid-log phase (optical density at 650 nm [OD 650 ] of Ϸ0.5), and samples containing an equivalent number of cells were resuspended in Laemmli solubilization buffer (57) . Whole-cell extracts were resolved by SDS-PAGE (10%) and visualized by Coomassie brilliant blue staining or electroblotted for 1.5 h at 45 V onto Hybond ECL (enhanced chemiluminescence) nitrocellulose (Amersham Pharmacia Biotech, Little Chalfont, Buckinghamshire, England). The positions of OmpT and OmpU were determined through comparisons of the wild-type strain with ompT and ompU mutants and by immunodetection of OmpT and OmpU (58) (data not shown). Immunodetection of ToxR was carried out using rabbit polyclonal anti-ToxR antiserum (diluted 1:1,000) (generous gift of R. K. Taylor), and horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Bio-Rad Laboratories, Hercules, CA) secondary antibody (diluted 1:10,000). Equal loading of the samples for immunoblotting was confirmed by evaluating the corresponding Coomassie-stained gel.
RNA isolation and microarray analysis. Strains were grown to midlog phase (OD 650 of Ϸ0.5) in T medium supplemented with 0.2% sucrose, 20 M FeSO 4 , and a mix of vitamins, as described above. The cultures were then divided, and amino acid solutions were added to a final concentration of 50 mM total amino acids. Cultures were grown for an additional 15 min and then treated with an RNase-free solution of 95% absolute ethanol-5% phenol (pH 4.5), used at 20% vol/vol, and kept on ice. RNA was isolated from 10 9 cells per sample using the RNeasy minikit (Qiagen) as per the manufacturer's instructions for isolation of total RNA from bacterial cells. Following purification, each RNA sample was treated with DNase I (Invitrogen) as per the manufacturer's protocol. The RNA samples were ethanol precipitated, dried, resuspended in RNase-free water, and quantified using an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE). For microarray analysis, approximately 20 g RNA per sample was used to generate cDNA for hybridization to V. cholerae NimbleChip_X4 microarray slides (NimbleGen Systems, Roche Diagnostics Operations, Inc., Indianapolis, IN). The microarray slides were processed by the Genomic Sequencing and Analysis Facility at the University of Texas, Austin, according to the NimbleGen system's protocols. The slides were scanned with GenePix 4000B Scanner (Axon Instruments, Molecular Devices, Sunnyvale, CA) and normalized using the GenePix software.
In vivo competition assays. Animal experiments were performed according to protocols approved by the University of Texas Institutional Animal Care and Use Committee. In vivo competition assays were performed using 5-day-old BALB/c mice in a modified version of the protocol described by Taylor et al. (33) . The two competing strains were the wild-type strain N16961G, containing an insertion of a gentamicin resistance cassette in the Tn7att site, and the NCsrA.R6H point mutant strain. We chose to mark the wild-type strain rather than the CsrA point mutant strain in order to avoid any adverse effects of the gentamicin cassette on the fitness of the mutant strain, which might skew the results. The infant mice were inoculated intragastrically with 50 l saline containing 0.02% Evan's blue dye and approximately 10 5 CFU of each competing strain grown to the mid-log phase in LB medium. The inoculation mixture was also diluted and plated, first on medium containing an antibiotic permissive for all V. cholerae El Tor stains (polymyxin B) and then on selective medium by patching in order to assess the input ratio of mutant to wildtype bacteria in the inoculum. The mice were sacrificed after 18 h, and the intestines were removed. The intestines of all the animals were visibly distended, consistent with significant fluid accumulation due to V. cholerae infection. The intestines were homogenized in 10 ml of sterile saline, and serial dilutions were plated on medium allowing recovery of both strains. Replica plating on differential medium by patching was then performed to determine the viable counts for each competing strain. The output ratios were normalized to the input ratios to determine the competitive index (CI): CI ϭ (mutant output/wild-type output)/(mutant input/wild-type input). Differential medium patching was performed on up to 230 recovered colonies from each mouse, setting the limits of detection for the competitive index at approximately 0.005. Examples of both gentamicin-sensitive and -resistant colonies recovered from infection were analyzed by sequencing to verify the presence or absence, respectively, of the point mutation in the csrA gene.
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